• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过智能热比较/判断和控制的自动温度补偿系统设计,实现高热腹腔内化疗(HIPEC)手术中的稳定热治疗。

The Design of an Automatic Temperature Compensation System through Smart Heat Comparison/Judgment and Control for Stable Thermal Treatment in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Surgery.

机构信息

Medical Devices R&D Center, Gachon University Gil Medical Center, 21, 774 Beon-gil, Namdong-daero, Namdong-gu, Incheon 21565, Republic of Korea.

Department of Biomedical Engineering, College of Medicine, Gachon University, 38-13, 3 Beon-gil, Dokjom-ro 3, Namdong-gu, Incheon 21565, Republic of Korea.

出版信息

Sensors (Basel). 2023 Jul 27;23(15):6722. doi: 10.3390/s23156722.

DOI:10.3390/s23156722
PMID:37571507
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10422214/
Abstract

After surgery for ovarian cancer or colorectal cancer, residual tumors are left around. A practical way to treat residual tumors is to destroy them with heat by injecting high-temperature drugs into the abdominal cavity. The injected medicinal substances are induced to flow out of the abdominal cavity; then, the spilled drug flows back into the abdominal cavity through feedback. During this process, the heat starts to decrease; thus, the treatment performance reduces. To overcome this problem, this study compares and assesses the temperature needed to maintain the heat for treatment and transmits a command signal to the heat exchanger through a look-up table (LUT). When the temperature decreases during the circulation of medications leaking out of the abdominal cavity, the LUT transmits a control signal () to the heat exchanger, which increases or vice versa. However, if the temperature () is within the treatment range, the LUT sends a signal to the heat exchanger. This principle generates a pulse signal for the temperature difference () in TC by comparing and determining the temperature () of the substance flowing out of the abdominal cavity with the reference temperature () through the temperature comparator (TC). At this time, if the signal is 41 °C or less, the LUT generates (heats) a signal so that the temperature of the heat exchanger can be maintained in the range of 41 °C to 43 °C. If the is 44 °C or higher, the LUT generates (cools) the T signal and maintains the temperature of the heat exchanger at 41-43 °C. If the is maintained at 41-43 °C, the LUT generates a signal to stop the system performance. At this time, the TC operation performance and generation process for comparing and determining the signal of and for drugs leaking out of the abdominal cavity is very important. It was observed that the faster the response signal, the lower the comparison and judgment error was; therefore, the response signal was confirmed to be 0.209 μs. The proposed method can guarantee rapid/accurate/safe treatment and automatically induce temperature adjustment; thus, it could be applied to the field of surgery.

摘要

在卵巢癌或结直肠癌手术后,会在周围留下残余肿瘤。一种实用的治疗残余肿瘤的方法是通过向腹腔内注射高温药物来用热破坏它们。注入的药物被诱导流出腹腔;然后,溢出的药物通过反馈流回腹腔。在这个过程中,热量开始下降;因此,治疗效果降低。为了克服这个问题,本研究比较和评估了维持治疗所需的热量所需的温度,并通过查找表 (LUT) 将命令信号传输到热交换器。当药物从腹腔漏出循环时温度降低时,LUT 向热交换器发送控制信号 (),反之亦然。但是,如果温度 ()在治疗范围内,LUT 会向热交换器发送信号。该原理通过比较和确定流出腹腔的物质的温度 ()与参考温度 ()通过温度比较器 (TC) 来为 TC 中的温度差 () 生成脉冲信号。此时,如果信号为 41°C 或更低,LUT 生成 () 信号,以使热交换器的温度可以保持在 41°C 至 43°C 的范围内。如果 为 44°C 或更高,则 LUT 生成 () 信号并将热交换器的温度保持在 41-43°C。如果保持在 41-43°C,则 LUT 生成信号以停止系统性能。此时,对于比较和确定流出腹腔的药物的信号和的 TC 操作性能和生成过程非常重要。观察到响应信号越快,比较和判断误差越低;因此,确认响应信号为 0.209 μs。该方法可以保证快速/准确/安全的治疗,并自动进行温度调节;因此,它可以应用于手术领域。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/10422214/078fa3c07f3d/sensors-23-06722-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/10422214/b08a88f44414/sensors-23-06722-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/10422214/138335eff17c/sensors-23-06722-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/10422214/1ba2b68041f7/sensors-23-06722-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/10422214/d78fa1d3ad4d/sensors-23-06722-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/10422214/10fd749c6233/sensors-23-06722-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/10422214/ad1a2e2474f0/sensors-23-06722-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/10422214/59cc87252c7c/sensors-23-06722-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/10422214/1823d1dce6c4/sensors-23-06722-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/10422214/00a88c9a8c4e/sensors-23-06722-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/10422214/04d575952600/sensors-23-06722-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/10422214/5a3a3bc182e2/sensors-23-06722-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/10422214/56566d7b1016/sensors-23-06722-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/10422214/1a4dcc30a7b8/sensors-23-06722-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/10422214/078fa3c07f3d/sensors-23-06722-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/10422214/b08a88f44414/sensors-23-06722-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/10422214/138335eff17c/sensors-23-06722-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/10422214/1ba2b68041f7/sensors-23-06722-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/10422214/d78fa1d3ad4d/sensors-23-06722-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/10422214/10fd749c6233/sensors-23-06722-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/10422214/ad1a2e2474f0/sensors-23-06722-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/10422214/59cc87252c7c/sensors-23-06722-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/10422214/1823d1dce6c4/sensors-23-06722-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/10422214/00a88c9a8c4e/sensors-23-06722-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/10422214/04d575952600/sensors-23-06722-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/10422214/5a3a3bc182e2/sensors-23-06722-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/10422214/56566d7b1016/sensors-23-06722-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/10422214/1a4dcc30a7b8/sensors-23-06722-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/10422214/078fa3c07f3d/sensors-23-06722-g014.jpg

相似文献

1
The Design of an Automatic Temperature Compensation System through Smart Heat Comparison/Judgment and Control for Stable Thermal Treatment in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Surgery.通过智能热比较/判断和控制的自动温度补偿系统设计,实现高热腹腔内化疗(HIPEC)手术中的稳定热治疗。
Sensors (Basel). 2023 Jul 27;23(15):6722. doi: 10.3390/s23156722.
2
Comparative Sensing and Judgment Control System for Temperature Maintenance for Optimal Treatment in Hyperthermic Intraperitoneal Chemotherapy Surgery.用于高热腹腔内化疗手术中最佳治疗的温度维持的比较感知和判断控制系统。
Sensors (Basel). 2024 Jan 17;24(2):596. doi: 10.3390/s24020596.
3
The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines.高温腹腔内热化疗(HIPEC)中顺铂类药物丝裂霉素 C 和 5-FU 的温度依赖性在结直肠癌细胞系中的作用。
Cells. 2020 Jul 25;9(8):1775. doi: 10.3390/cells9081775.
4
Intra-abdominal temperature distribution during consolidation hyperthermic intraperitoneal chemotherapy with carboplatin in the treatment of advanced stage ovarian carcinoma.卡铂巩固性腹腔内热灌注化疗治疗晚期卵巢癌时的腹腔内温度分布
Int J Hyperthermia. 2015 Jun;31(4):396-402. doi: 10.3109/02656736.2015.1007399. Epub 2015 Feb 24.
5
Demonstration of treatment planning software for hyperthermic intraperitoneal chemotherapy in a rat model.演示用于大鼠模型的腹腔内热化疗治疗计划软件。
Int J Hyperthermia. 2021;38(1):38-54. doi: 10.1080/02656736.2020.1852324.
6
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin.通过改良灌注系统进行热灌注化疗(HIPEC)的细胞减灭术用于结直肠源性腹膜癌病。
Surg Today. 2016 Aug;46(8):979-84. doi: 10.1007/s00595-016-1335-3. Epub 2016 Apr 30.
7
Abdomino-pelvic hyperthermia and intraperitoneal carboplatin in epithelial ovarian cancer: feasibility, tolerance and pharmacology.上皮性卵巢癌的腹腔-盆腔热疗及腹腔内卡铂治疗:可行性、耐受性及药理学
Int J Radiat Oncol Biol Phys. 1996 Jul 15;35(5):993-1001. doi: 10.1016/0360-3016(96)00092-2.
8
Efficacy and safety of intraperitoneal bevacizumab combined with hyperthermic intraperitoneal chemotherapy in the treatment of patients with ovarian cancer and peritoneal effusion and the effect on serum lncRNA H19 and VEGF levels.腹腔内注射贝伐单抗联合热灌注腹腔化疗治疗卵巢癌伴腹腔积液患者的疗效和安全性及其对血清lncRNA H19和VEGF水平的影响。
J Obstet Gynaecol. 2023 Dec;43(1):2204940. doi: 10.1080/01443615.2023.2204940.
9
Survival After Hyperthermic Intraperitoneal Chemotherapy and Primary or Interval Cytoreductive Surgery in Ovarian Cancer: A Randomized Clinical Trial.卵巢癌患者行腹腔内热灌注化疗联合初次或间隔细胞减灭术的生存情况:一项随机临床试验。
JAMA Surg. 2022 May 1;157(5):374-383. doi: 10.1001/jamasurg.2022.0143.
10
[Construction and evaluation of a nomogram for predicting the prognosis of patients with colorectal cancer with peritoneal carcinomatosis treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].[用于预测接受细胞减灭术加腹腔内热灌注化疗的结直肠癌伴腹膜转移患者预后的列线图的构建与评估]
Zhonghua Wei Chang Wai Ke Za Zhi. 2023 May 25;26(5):434-441. doi: 10.3760/cma.j.cn441530-20230309-00071.

本文引用的文献

1
Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review.卵巢癌筛查与诊断的当前及新兴方法:全面综述
Cancers (Basel). 2022 Jun 11;14(12):2885. doi: 10.3390/cancers14122885.
2
Current role for cytoreduction and HIPEC for gastric cancer with peritoneal disease.胃癌伴腹膜疾病行细胞减灭术和 HIPEC 的现状。
J Surg Oncol. 2022 Jun;125(7):1176-1182. doi: 10.1002/jso.26894.
3
Toward More Comprehensive Homologous Recombination Deficiency Assays in Ovarian Cancer Part 2: Medical Perspectives.
迈向更全面的卵巢癌同源重组缺陷检测 第2部分:医学视角
Cancers (Basel). 2022 Feb 21;14(4):1098. doi: 10.3390/cancers14041098.
4
Past, Present, and Future of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer.热灌注化疗(HIPEC)在卵巢癌治疗中的过去、现在与未来
Cureus. 2021 Jun 10;13(6):e15563. doi: 10.7759/cureus.15563. eCollection 2021 Jun.
5
Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study.二期手术加腹腔内热灌注化疗与监测在有发生结直肠腹膜转移高危患者中的对比(PROPHYLOCHIP-PRODIGE 15):一项随机、3 期研究。
Lancet Oncol. 2020 Sep;21(9):1147-1154. doi: 10.1016/S1470-2045(20)30322-3. Epub 2020 Jul 24.
6
Current Trends of Artificial Intelligence for Colorectal Cancer Pathology Image Analysis: A Systematic Review.人工智能用于结直肠癌病理图像分析的当前趋势:一项系统综述
Cancers (Basel). 2020 Jul 13;12(7):1884. doi: 10.3390/cancers12071884.
7
Radiotherapy side effects: integrating a survivorship clinical lens to better serve patients.放疗副作用:融入生存临床视角,更好地为患者服务。
Curr Oncol. 2020 Apr;27(2):107-112. doi: 10.3747/co.27.6233. Epub 2020 May 1.
8
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017.韩国癌症统计数据:2017 年发病率、死亡率、生存率和患病率。
Cancer Res Treat. 2020 Apr;52(2):335-350. doi: 10.4143/crt.2020.206. Epub 2020 Mar 16.
9
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Mitomycin C Used for Colorectal Peritoneal Carcinomatosis.丝裂霉素C用于结直肠癌腹膜转移癌的细胞减灭术和腹腔内热灌注化疗
Ann Coloproctol. 2020 Feb;36(1):22-29. doi: 10.3393/ac.2019.04.30. Epub 2020 Feb 29.
10
The "homemade" HIPEC machine - a cost-effective alternative in low-resource countries.“自制”的腹腔热灌注化疗(HIPEC)机器——低资源国家中一种经济高效的替代方案。
Pleura Peritoneum. 2017 Dec 1;2(4):163-170. doi: 10.1515/pp-2017-0022. Epub 2017 Nov 2.